Helmy Eltoukhy, Co-Chief Executive Officer at Guardant Health, Inc. (GH), bought 177,504 shares at $26.33 ($4.7M) on 2023-03-14, disclosed to the SEC on 2023-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.33 | 84,452 | $2.2M | 47.6% |
| 2 | $26.33 | 84,452 | $2.2M | 47.6% |
| 3 | $26.15 | 8,600 | $225K | 4.8% |
| Total | $26.32 avg | 177,504 | $4.7M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |
| GH | SELL | 2021-04-26 | $2.6M | — | Filing → |